Other: Magnetic Resonance Imaging (MRI) ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 113 | Muscular dystrophy | 1 |
113. Muscular dystrophy
Clinical trials : 622 / Drugs : 485 - (DrugBank : 99) / Drug target genes : 59 - Drug target pathways : 168
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02195999 (ClinicalTrials.gov) | December 2013 | 17/7/2014 | Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy | Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy | Muscular Dystrophy, Duchenne | Other: Magnetic Resonance Imaging (MRI);Other: Pulmonary Function Testing (PFT);Other: Metabolic Exercise Testing using stationary bicycle;Other: Echocardiogram | University of Florida | CureDuchenne | Completed | 5 Years | 15 Years | Male | 9 | United States |